Research funder · United States
Melanoma Research Alliance
Nonprofit organization in Washington D.C., United States
- Grants since 2016
- 400
- Awarded, last 5 years (where amounts are published)
- 72.1M
- Funded works, last 5 years
- 1 190
- Funded works, all time
- 2 826
Grants
2021–2024 · award
Immunotherapeutic cytokine/antibody fusion proteins to treat melanoma
Jamie Spangler
2021–2024 · award
Adipocyte remodelling in melanoma progression and immunotherapy response
Amaya Viros
2021–2024 · award
Targeting CDK6 in T cells for melanoma therapy
Haizhen Wang
2021–2024 · award
Dissecting Tumor and Immune Evolution in Unresectable In-Transit Melanoma
David Liu
2021–2024 · award
Enhancing tumour immune detection by targeting replication stress
Brian Gabrielli
2021–2024 · award
CD8+ Cell Imaging during Neoadjuvant ImmunoTherapy (The C-IT Neo Trial)
Michael Postow
2021–2022 · award
Novel biomarkers and treatment strategies for acral lentiginous melanomas
Dekker Deacon
2021–2022 · award
Evaluating acral pigmented lesions via AI algorithms in Black patients
Mariela Mitre
2021–2024 · award
Tailoring T cell anti-tumor response with mitochondria-mediated regulations
Ping-Chih Ho
2021–2023 · award
Harnessing proteasome heterogeneity for sensitization to immunotherapy
Yifat Merbl
2021–2024 · award
Dissecting the role of CD58 in cancer immune evasion and T cell exclusion
Benjamin Izar
2021–2024 · award
Tumor microbiome potentiates cancer immunotherapy in melanoma
Marlies Meisel
2021–2024 · award
Improving immunotherapy outcomes through solving irAEs
Alexandra-Chloe Villani
2021–2022 · award
Development of an enhanced telemedicine-based melanoma diagnostic platform
Shirin Bajaj
2021–2022 · award
Leveraging Social Media to Augment Education on Melanoma in Hispanics
Collin Costello
2021–2024 · award
PARP14 mediates adaptive resistance to immune checkpoint inhibitors
Adam Hurlstone
2021–2022 · award
Towards a multimodal imaging approach for in vivo melanoma diagnosis
Aditi Sahu
2021–2023 · award
IDENTIFYING AND TARGETING MELANOMA RESIDENT MACROPHAGES
Andrew White
2021–2024 · award
Balancing stem-like and effector T cells for maximal anti-tumor activity
Thorsten Mempel
2021–2024 · award
Ablative radiotherapy as consolidation for oligoprogressive melanoma
Reid Thompson
2021–2022 · award
Determining the Immune Inhibitory Landscape in Melanoma
Matthew Vesely
2021–2024 · award
Formation and Function of Tertiary Lymphoid Structures in Melanoma
Victor Engelhard
2021–2024 · award
Identifying defects in nucleic acid sensing that drive anti-PD-1 resistance
Rizwan Haq
2021–2023 · award
Defining mediators of metastatic spread in acral melanoma
Carla Daniela Robles-Espinoza
2021–2024 · award
Targeting neuroinflammation for inhibition of melanoma brain metastasis
Neta Erez
2021–2023 · award
Overcoming immunotherapy resistance by selective inhibition of Notch1
Barbara Bedogni
2021–2022 · award
Distant Metastasis by Early ALM in Patients with Skin of Color
Zhentao Yang
2021–2024 · award
Targeting Liver Metastases to Enhance Immunotherapy Efficacy in Melanoma
Michael Green
2020–2023 · award
Genomic instability in acral melanoma as a therapeutic vulnerability
Boris Bastian
2020–2022 · award
Molecular predictors and vulnerabilities of melanoma brain metastasis
Michael Davies
2020–2023 · award
Next-generation computational biomarker development for PD-(L)1 efficacy
Janis Taube
2020–2022 · award
The impact of tumor progression trajectory on immunotherapy treatment
Lixing Yang
2020–2021 · award
Diagnosis of melanoma using machine learning and confocal microscopy
Jonathan Kentley
2020–2023 · award
Targeting 1-Carbon Metabolism in Melanoma Brain Metastases
Michael Pacold
2020–2022 · award
Uncovering Nodes of Convergence of Targeted and Immune Therapy in Melanoma
Poulikos Poulikakos
2020–2023 · award
IL13Ra2 Chimeric Antigen Receptor (CAR) T cells for Metastatic Melanoma
Antoni Ribas
2020–2023 · award
Understanding Immunotherapy-Tolerant Melanoma Persister Cells
Matthew Hangauer
2020–2022 · award
Sensitizing melanoma to immunotherapy with novel DNA hypermethylating drugs
Alfonso Bellacosa
2020–2021 · award
Genomic Features of Primary Melanoma Predictive of Brain Metastasis
Yujue Wang
2020–2023 · award
Effective therapies for patinets with high risk in-transit disease
Richard Scolyer